Title : A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.

Pub. Date : 2019 Jan 1

PMID : 30190369






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib + mFOLFOX increased plasma PlGF, VEGF-D, sVEGFR1, IL12p70, and CAIX and CD4+ and CD8+ effector T lymphocytes and decreased plasma sVEGFR2 and s-c-KIT and regulatory T cells (Tregs). Sorafenib carbonic anhydrase 9 Homo sapiens